Recurrence and cancer-specific death after adjuvant chemotherapy for Stage III colon cancer.
P H ChapuisE BokeyC ChanA KeshavaM J F X RickardP StewartChristopher John YoungOwen F DentPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2018)
These findings question the routine use of chemotherapy after complete mesocolic excision for Stage III colon cancer. Recurrence and cancer-specific death, assessed by competing risk methods, should be the standard outcomes for evaluating the effectiveness of adjuvant chemotherapy after potentially curative resection.